Renaissance Technologies (RenTech)'s NEO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 254,172 shares of NeoGenomics, Inc. (NEO) worth $1.89 M, representing 0.00% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 30 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in NEO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2017, adding 308,664 shares. Largest reduction occurred in Q1 2019, reducing 402,700 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s NeoGenomics (NEO) Holding Value Over Time
Track share changes against reported price movement
Quarterly NeoGenomics (NEO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +254,172 | New Buy | 254,172 | $7.42 |
| Q3 2024 | -15,300 | Sold Out | 0 | $0.00 |
| Q2 2024 | -126,300 | Reduce 89.19% | 15,300 | $13.87 |
| Q1 2024 | +41,800 | Add 41.88% | 141,600 | $15.72 |
| Q4 2023 | -123,300 | Reduce 55.27% | 99,800 | $16.18 |
| Q3 2023 | +223,100 | New Buy | 223,100 | $12.30 |
| Q2 2022 | -246,000 | Sold Out | 0 | $0.00 |
| Q1 2022 | +246,000 | New Buy | 246,000 | $12.15 |
| Q4 2019 | -119,500 | Sold Out | 0 | $0.00 |
| Q3 2019 | +119,500 | New Buy | 119,500 | $19.12 |
| Q1 2019 | -402,700 | Sold Out | 0 | $0.00 |
| Q4 2018 | +228,048 | Add 130.57% | 402,700 | $12.61 |
| Q3 2018 | +174,652 | New Buy | 174,652 | $15.35 |
| Q2 2018 | -40,100 | Sold Out | 0 | $0.00 |
| Q1 2018 | +40,100 | New Buy | 40,100 | $8.15 |
| Q2 2017 | -308,664 | Sold Out | 0 | $0.00 |
| Q1 2017 | +308,664 | New Buy | 308,664 | $7.89 |
| Q4 2016 | -251,000 | Sold Out | 0 | $0.00 |
| Q3 2016 | -256,200 | Reduce 50.51% | 251,000 | $8.22 |
| Q2 2016 | +172,500 | Add 51.54% | 507,200 | $8.04 |
| Q1 2016 | -141,900 | Reduce 29.77% | 334,700 | $6.74 |
| Q4 2015 | +156,100 | Add 48.71% | 476,600 | $7.87 |
| Q3 2015 | -17,400 | Reduce 5.15% | 320,500 | $5.73 |
| Q2 2015 | +93,500 | Add 38.26% | 337,900 | $5.41 |
| Q1 2015 | +107,700 | Add 78.79% | 244,400 | $4.67 |
| Q4 2014 | -65,800 | Reduce 32.49% | 136,700 | $4.17 |
| Q3 2014 | +202,500 | New Buy | 202,500 | $5.21 |
| Q2 2014 | -29,096 | Sold Out | 0 | $0.00 |
| Q1 2014 | +6,997 | Add 31.66% | 29,096 | $3.47 |
| Q4 2013 | +22,099 | New Buy | 22,099 | $3.62 |
Renaissance Technologies (RenTech)'s NeoGenomics Investment FAQs
Renaissance Technologies (RenTech) first purchased NeoGenomics, Inc. (NEO) in Q4 2013, acquiring 22,099 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held NeoGenomics, Inc. (NEO) for 30 quarters since Q4 2013.
Renaissance Technologies (RenTech)'s largest addition to NeoGenomics, Inc. (NEO) was in Q1 2017, adding 308,664 shares worth $2.44 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 254,172 shares of NeoGenomics, Inc. (NEO), valued at approximately $1.89 M.
As of the Q1 2026 filing, NeoGenomics, Inc. (NEO) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in NeoGenomics, Inc. (NEO) was 507,200 shares, as reported at the end of Q2 2016.